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1. Introduction  
Industrial interest in microbial polymers has been stimulated by their unique properties and 
the opportunity to develop new materials, which can be used for specific applications in 
medical and pharmaceutical industries. Azotobacter vinelandii produces two polymers of 
biotechnological importance; alginate, an extracellular polysaccharide, and poly-ǃ-
hydroxybutyrate (PHB), an intracellular polyester of the polyhydroxyalkanoates (PHAs) 
family (Galindo et al., 2007). Alginates are linear polysaccharides composed of variable 
amounts of (1–4)-ǃ-D-mannuronic acid and its epimer, ǂ-L-guluronic acid. Alginates present 
a wide range of applications, acting as stabilizing, thickening, gel or film-forming agents, in 
various industrial fields. Currently, new applications are being discovered for these 
polymers, such as their use as a source of soluble fiber, or in medical products. One example 
is found in the use of alginate gel beads as entrapment devices for transplantation of e. g. 
insulin producing cells and tissue engineering (Hernández et al., 2010).  
The intracellular polyester PHB and other PHAs have been drawing attention because 
they are biodegradable and biocompatible thermoplastics, which can be processed to 
create a wide variety of consumer products, including plastics, films, and fibers (Aldor & 
Keasling, 2003). Recently, and based on their properties of biocompatibility and 
biodegradability, new attractive applications for PHAs have been proposed in the medical 
field, where the chemical composition and product purity are critical (Williams & Martin, 
2005). 
The subjects covered in this chapter include research concerning the production of alginate 
and PHB by A. vinelandii, particularly the molecular regulation of the production of these 
polymers, the influence of fermentation parameters on the production and composition of 
alginate and PHB, some reports about the scaling-up of the process and downstream 
processing, and finally, novel fermentation strategies that could be applied for the 
production of alginate and PHAs by A. vinelandii. 
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2. Structure and physical properties of alginate and PHAs 
Alginates are polysaccharides constituted by variable amounts of ǃ-D-mannuronic acid and 
its C5-epimer ǂ-L-guluronic acid linked by 1-4 glycosidic bonds (Figure 1). The monomers 
are distributed in blocks of continuous mannuronate residues (M), guluronate residues (G) 
or alternating residues (MG) (Smidsrod & Draget,1996). Azotobacter alginates are true block 
co-polymers, composed of homopolymeric regions of M and G residues, separated by 
regions of alternating structure (Clementi, 1997). Unlike alginates produced by algae, 
bacterial alginates are acetylated to a variable extent at positions O-2 and/or O-3 of the 
mannuronate residues (Skjak-Braek et al., 1986). The variability in molecular mass, 
monomer block structure and acetylation influence the physicochemical and rheological 
characteristics of the polymer. 
The capability of alginate to confer viscosity in solution is dependent on its molecular mass 
(MM). The MM of algal alginates has been found to range from 48 to 186 kDa (Donnan & 
Rose, 1950). In contrast, some alginates isolated from A. vinelandii present MM in the range 
of 80 to 4,000 kDa (Galindo et al., 2007). 
The gelling properties of alginate are based on the affinity of the molecule towards certain 
ions, especially Ca++, and the ability to bind these ions selectively and cooperatively. 
Selective ion binding is related to the content of G residues, in particular the length of the G-
blocks. Alginates rich in G residues show an increased ionic binding, resulting in enhanced 
mechanical rigidity (Grant et al., 1973). Alginates with a low M/G ratio form strong and 
brittle gels, while alginates with a high M/G ratio form weaker and softer, but more elastic 
gels (Skjak-Braek et al., 1986). 
Bacterial alginates which are O-acetylated, have a polyelectrolyte behaviour different from 
that of the non-acetylated algal alginates. This is because acetyl groups strongly perturb 
stereoregular sequences and produce significant conformational effects. In addition, the 
presence of acetyl groups diminishes the binding capacity and the selectivity coefficient for 
cations, affecting the gelling properties of alginate. The presence of O-acetyl groups in 
bacterial alginates might represent an advantage for certain applications, as it has been 
demonstrated that they improve the viscosity and enhance the swelling ability of the 
polymer (Clementi, 1997; Peña et al., 2006). 
On the other hand, polyhydroxyalkanoates (PHAs) are aliphatic polyesters generally 
composed of ǃ-hydroxy fatty acid monomers in which the carboxyl group of one monomer 
forms an ester bond with the hydroxyl group of the neighboring monomer (Madison & 
Huisman, 1999; Figure 1). The MM of PHAs is dependent on the bacterial species used and 
culture conditions but is generally on the order of 50 to 1,000 kDa (Madison & Huisman, 
1999). At present, more than 150 different hydroxyalkanoate constituents have been 
reported in PHAs, as homopolyesters or as copolyesters (Steinbuchel & Lutke-Eversloh, 
2003). These highly diverse polymers can be classified according to the size of the 
comprising monomers. PHAs containing monomers with C4–C5 atoms are categorized as 
short-chain-length PHAs (scl-PHAs). In contrast, medium-chain-length PHAs (mcl-PHAs) 
are composed of C6–C14 ǃ-hydroxy fatty acids (Lee, 1996). Most bacteria synthesize either 
scl-PHAs or mcl-PHAs (Madison & Huisman, 1999). scl-PHAs have properties close to 
conventional plastics, while the mcl-PHAs are regarded as elastomers and rubbers 
(Suriyamongkol et al., 2007). 
Polyhydroxybutyrate (PHB) is the more abundant PHA and has been studied extensively. 
This polymer has some mechanical properties similar to conventional plastics like 
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polypropylene or polyethylene, although it is highly crystalline and stiff, leading to 
brittleness and low elongation to break (Khanna & Srivastava, 2005). Initial biotechnological 
developments were aimed at making PHAs easier to process. Because the monomeric 
composition of a PHA is crucial for its mechanical properties, the incorporation in the PHB 
polymer of secondary monomer units(s) such as ǃ-hydroxyvalerate (3HV) improves the 
characteristics of the material obtained. For example, a random copolymer of 3HB and 3HV 
is more ductile, easier to mold, and tougher than PHB homopolymer (Taguchi & Doi, 2004), 
and it can be used to prepare films with excellent water and gas barrier properties 
reminiscent of polypropylene, and can be processed at a lower temperature while retaining 
most of the other mechanical properties of PHB. 
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Fig. 1. Chemical structure of PHAs (a) and Alginate (b). M, mannuronic acid; G, guluronic 
acid; Ac, acetyl. R, alkyl group. 
3. Novel applications of alginate and PHAs 
3.1 Novel applications of alginates 
Novel alginates applications have been focused on pharmaceutical and biomedical fields, 
because they are non-toxic, biocompatible, non-immunogenic, hydrophilic and 
biodegradable material (Augst et al., 2006; Hernández et al., 2010). Alginate hydrogels can 
be used as bulking materials for in vivo and in vitro cell immobilization, like drug controlled 
delivery system, for tissue engineering (Augst et al., 2006; Hernández et al., 2010), and 
alginate conjugates have also been tested as antigens to control cystic fibrosis (Kashef et al., 
2006), and other bacterial infections (H. Sun et al., 2007). During the last three decades, 
microencapsulation using alginate has been investigated to deliver and protect from the 
host immune system, not only drugs, but also transplanted cells (Hoesli et al., 2011). The 
materials used for these molecular/cell immobilization require to be biocompatible and bio-
inert, with certain size and shape. In addition, alginates have been used as scaffold for tissue 
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engineering, and chemical modifications that increase alginate biocompatibility or cell 
adhesion have been developed. The polysaccharide can be modified by coupling proteins 
and peptides, allowing the control of cell attachment (Augst et al., 2006; Hernández et al., 
2010). The biomimetic gel design provides in vivo long-term functionality and higher 
mechanical stability (Hernández et al., 2010). 
Some therapeutic applications of alginate microencapsulation are related with drug 
delivery. For low-molecular weight drugs, regulating drug-alginate interactions in alginate 
gels allows the control of drug release. This is especially important for drugs that have 
severe side effects, like antineoplastic agents. Besides, some proteins with therapeutic 
activities can be alginate-microencapsulated to improve their efficacy and targeting, because 
alginate encapsulation facilitate a localized delivery without adverse side effects. Alginate 
microencapsulation has been proven with basic fibroblast growth factor (bFGF) and 
vascular endothelial growth factor (VEGF). The release of VEGF is controlled by the 
dissolution of the ionic binding complex between alginate and VEGF and subsequent 
diffusion, showing a constant release rate for several weeks (Augst et al., 2006). 
Alginate has been successfully used for cell microencapsulation, which is of great 
importance for Diabetes Mellitus type 1 treatment, where several efforts have been made for 
regulated insulin supply for treating insulin-dependent patients (Hernández et al., 2010). 
Moreover, there are several new strategies developed to improve the cell-alginate 
immobilization process (Hoesli et al., 2011), as well as immune protection and oxygen 
supply to avoid hypoxia problems during transplants (Ludwig et al., 2010). In the tissue 
engineering field, alginate has been used for bone regeneration therapy using co-
immobilization of human osteoprogenitors and endothelial cells in studies in vivo and in 
vitro (Hernández et al., 2010). Other important applications of alginate for tissue engineering 
are related to neurological and cardiologic tissue regeneration (Hernández et al., 2010). 
Pseudomonas aeruginosa is the most common pathogen responsible for morbidity and 
mortality in cystic fibrosis patients. During infection, this bacterium produces alginate, 
which is an important virulence factor (Kashef et al., 2006). For this reason, alginate has been 
used for vaccine design, against P. aeruginosa. Vaccines based on purified alginate bring 
poor immunogenicity (Dörig & Pier, 2008); however, when alginate is conjugated with 
proteins, the immune response could be enhanced (Dörig & Pier, 2008; Kashef et al., 2006). 
Kashef et al., (2006) designed an alginate-tetanus toxoid conjugate non-toxic, non pyrogenic, 
which was able to protect mice against a lethal dose of mucoid P. aeruginosa. It is important 
to point out that alginate viscosity plays an important role for the P. aeruginosa protection 
during the infection process. Because of this, it has been proposed to induce changes in the 
rheology of the alginate by addition of alginate olygoelectrolytes conformed by G blocks 
only (Draget & Taylor, 2011). These oligoguluronates reduce the mechanical response of the 
polymer synthesized by P. aeruginosa in patients diagnosed with cystic fibrosis (Draget & 
Taylor, 2011).  
Alginates have also been studied for development of novel immunotherapy strategies for 
cancer treatment using dendritic cells which are potent initiators of immune response. Calcium 
cross-linked alginate gels carrying dendritic cells initiated the immune response and allowed 
the migration of the immune cells through the alginate gel (Hori et al., 2008, 2009). 
3.2 Novel applications for PHAs 
PHAs have received much attention as candidates to produce biodegradable plastics 
compatible with the environment, due to their material properties (similar to those of well-
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known plastics such as polypropylene), their production from renewable sources, and their 
inherent biodegradability in various environments (Taguchi & Doi, 2004). These 
biopolyesters are attractive to replace non-biodegradable plastics, especially for those 
products that usually have single-use applications, such as food packaging.  
 
Material Application Desirable properties Reference 
 
Alginate 
Drug delivery Gel formation/ 
Biocompatible/ 
Bioinert/ Biodegradable/ 
Drug alginate interaction 
Augst et al., 2006 
Cell 
immobilization  
Gel formation/ 
Biocompatible/ 
Bioinert/ Diffusion 
Hernández et al., 2010 
Hoesli et al., 2011 
Tissue Engineering Gel formation/ 
Biocompatible/ 
Bioinert/Diffusivity 
Hernández et al., 2010 
Vaccines against 
Pseudomonas 
aeruginosa 
Immunogenicity Kashef et al., 2006 
Mucus alteration Low Viscosity Draget & Taylor, 2011 
Cancer therapy Gel formation/ 
Biocompatible/ 
Bioinert/ Diffusivity 
Hori et al., 2008 
 
PHA 
Bioplastics Thermoplasticity, physical and 
mechanical resistance/ 
Biodegradable 
Chen, 2009 
Tissue Engineering Thermoplasticity, physical and 
mechanical resistance/ 
Biocompatible 
Wu et al., 2009  
Grage et al., 2009 
Drug delivery Biocompatible/ Biodegradable Chen, 2009 
Cell 
microencapsulation 
and 
nanoencapsulation 
Biocompatible/ Biodegradable Grage et al., 2009 
Affinity support Biocompatible Lee et al., 2005 
Wang et al., 2008 
Affinity 
chromatography 
Biocompatible  
Biomarkers/ 
Biosensors 
Biocompatible Grage et al., 2009 
 
Biofuels Biodegradability/ Methyl 
esterification capability 
Zhang et al., 2009 
Table 1. Novel applications of Alginate and PHAs. 
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Some of the monomers present in PHAs are known to be present in human and animals. For 
example, the monomeric component of PHB (ǃ-hydroxybutyrate) is a ketone body normally 
found in human blood (Williams & Martin, 2005). The biocompatibility, together with the 
adjustable mechanical properties, and controllable biodegradability of PHAs have raised 
interesting applications in the medical field. These polymers have been used in artificial 
organ construction, drug delivery, tissue repair, and nutritional/therapeutic uses (Chen & 
Wu, 2005; Freier, 2006; Grage et al., 2009; Valappil et al., 2006; Williams & Martin, 2005; Wu 
et al., 2009; Zinn et al., 2001). Because several PHAs are available now in sufficient quantity, 
some of them have been used in biocompatibility studies in vivo (Valappil et al., 2006). Some 
of the medical devices tested with different degrees of success include meniscus repair 
devices, staples, screws, bone plating systems, cardiovascular patches, stents and nerve 
guides (Wu et al., 2009). 
Very interesting applications for PHAs are found in the fabrication of drug delivery devices. 
Their biocompatibility, combined with their biodegradation, make them good candidates for 
this purpose (Chen, 2009). The possibility to create PHAs of various monomeric 
compositions and molecular weights makes possible the fine control of their degradation 
rate (Wu et al., 2009). Several drugs have been entrapped or microencapsulated in PHA 
homopolymers or copolymers, such as, anticancer agents, antihypertensives, hormones, 
vaccines, etc. (Williams & Martin, 2005). 
More recently, new applications have been reported for PHAs, not just as a material but for the 
PHA granules themselves as micro-nano beads, resulting in applications for protein 
purification and specific drug delivery (Grage et al., 2009). Affinity protein purification 
methods make use of an affinity tag fused to the protein of interest. The interaction of the 
tagged protein with an immobilizing matrix allows the separation of the protein. PHA 
granules have been used as an inexpensive affinity support, while the phasins, PHA synthase, 
or PHA depolymerase, proteins naturally associated with the granules, work as the affinity tag 
for the purification or immobilization of proteins (Lee et al., 2005; Wang et al., 2008). 
Combining the fusion of the protein of interest with the phasin protein (PhaP), intein mediated 
self-cleavage, and PHA synthesis in recombinant Escherichia coli, specific proteins can be 
produced together with their insoluble matrix, and after cell disruption, precipitation and self-
cleavage, the purified protein is released (Banki et al., 2005; Mee at al., 2008). A similar method 
using Cupriavidus necator instead of E. coli has been developed (Barnard et al., 2005).  
PHA nanoparticles have also been used in drug delivery, target specific therapy and as 
biomarkers or biosensors (Grage et al., 2009). Using the same principle of affinity binding of 
PHA synthase to PHA granules, Brockelbank et al., (2006) demonstrated the display of 
antigen fragments at the surface of PHA beads, showing their potential to be used in 
immunoglobulin G (IgG) purification from human serum. The functional display of antigen 
or antibodies fragments at the bead surface can be used for diagnostic or therapeutic 
applications (Grage et al., 2009). Fusion of PHA synthase with streptavidin has shown that 
these PHA beads can also be used for ELISA, DNA purification, enzyme immobilization and 
flow cytometry (Peters & Rhem, 2008). Engineered proteins for inorganics, like gold or silica, 
or IgG, have also been fused to the PHA synthase, and displayed at the surface of PHA 
granules, so these biobeads can be used for medical bioimaging procedures as inorganic 
contrast agents (Grage et al., 2009; Jahns et al., 2008). 
With respect to targeted drug delivery, Yao et al., (2008) demonstrated that phasins can be 
fused to ligands recognized by tissue specific receptors, and that the ligand-PhaP-nanobeads 
are taken up by the correct tissue in vivo, delivering drugs loaded in the PHA beads.  
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Other applications for PHAs include their use as fine chemicals. A high diversity of 
carboxylic acids, all in the (R)- configuration, can be obtained by depolymerization or by 
chemical degradation of PHAs, and these can be bulk chemicals for various applications 
(Chen, 2009). Some of them have been used as starting material for the synthesis of 
antibiotics, vitamins, aromatics and pheromones (Ruth et al., 2007). 
A new field of application for PHAs has been devised in the energy industry. These 
polymers can be used as biofuels (Chen, 2009). The conversion of PHB or mcl-PHAs to their 
methyl ester derivatives by acid catalyzed hydrolysis, allowed their use as fuels in blends 
with ethanol, gasoline, and diesel, with reasonable combustion heats (Zhang et al., 2009). 
4. Azotobacter vinelandii  
A. vinelandii is a gamma Proteobacteria having a strictly respiratory type of metabolism with 
oxygen as the terminal electron acceptor. Nitrogen is fixed at either microaerobic or fully 
aerobic conditions. Its growth is heterotrophic where sugars, alcohols and salts of organic 
acids are used as carbon source (Kennedy et al., 2005). Sugars are metabolized trough the 
Entner-Doudoroff pathway (Conway, 1992). The genus Azotobacter is distinguished by the 
ability to form metabolically dormant cyst in stationary phase or upon induction of 
vegetative cells with 0.2% of n-butanol. The cysts are significantly more resistant than 
vegetative cells to desiccation (Socolofsky & Wyss, 1962). Alginate is a component of the 
envelope that protects the cyst, and is essential for the resistance to desiccation (Campos et 
al., 1996). Upon induction of encystment intracellular accumulation of poly-ǃ-
hydroxybutyrate (PHB) occurs at an exponential rate; however recent data demonstrated 
that PHB was not essential for the formation of mature cysts (Segura et al., 2003a). 
The majority of nitrogen fixing bacteria are capable of reducing N2 only in anaerobic or 
microaerobic conditions. In contrast, A. vinelandii is an obligate aerobe capable of fixing N2 
even at high concentration of O2. This is possible because this bacterium can adjust oxygen 
consumption rates to help maintain low levels of cytoplasmic oxygen, which is otherwise 
detrimental not only for nitrogenase, but also to other oxygen-sensitive enzymes, a process 
that has been called respiratory protection (Poole & Hill, 1997). In addition to the respiratory 
protection of the nitrogenase, another way to keep the cytoplasm anaerobic is to prevent the 
O2 transfer into the cell. The polysaccharide alginate is believed to form a coating around the 
cell, acting as a physical O2 barrier (Sabra et al., 2000). This barrier has also been reported to 
protect the cell from heavy metals toxicity, as an ion-exchange system with high affinity to 
Ca++, or to provide a negatively charge coating which creates a barrier against attack and 
adverse environmental conditions (Clementi, 1997).  
5. Genetics and biosynthesis of alginates and PHAs in A. vinelandii 
5.1 Biosynthesis of alginates by A. vinelandii 
The pathway for alginate synthesis has been well established and it is conserved among 
brown algae, Pseudomonas and Azotobacter spp. (Lynn & Hassid, 1966; Pindar & Bucke, 1975). 
Fructose 6-P, the precursor of this metabolic pathway, is converted by four enzymatic 
reactions to GDP-mannuronic acid (for a detailed review see Galindo et al., 2007; 
Remminghorst & Rehm 2006). Polymerization of GDP-mannuronic acid is conducted by an 
inner membrane mannuronate polymerase (Alg8) and its activity is regulated by another 
inner membrane protein (Alg44), essential for alginate biosynthesis (Galindo et al., 2007). 
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The resultant poly-mannuronic acid is then modified by a periplasmic O-acetylase complex 
(AlgI, AlgV, AlgF) and some of the non-acetylated mannuronate residues are epimerized to 
guluronate by a periplasmic mannuronate epimerase (AlgG). The polymer is then exported 
through the outer membrane via the pore-forming protein AlgJ where the activity of several 
extracellular C-5 epimerases (AlgE1-7), present only in A. vinelandii generate alginates with 
different amounts of alternating structures and/or G-block lengths (Ertesvag et al., 1999). 
The molecular factors determining the molecular mass of the alginate remain largely 
unknown, but it has been suggested that it is the result of the polymerase and/or lyase 
activities on the polymer. In A. vinelandii, the existence of five alginate lyases showing 
different sequence cleavage specificity and cellular locations have been reported 
(Gimmestad et al., 2009; Trujillo-Roldán et al., 2003). The periplasmic AlgL protein is 
involved in the biosynthesis of the polysaccharide, while the extracellular AlgE7 (a bi-
functional alginate lyase and C-5 epimerase) and AlyA3 enzymes are involved in the release 
of the polymer from the cell surface and in the rupture of the cyst coat during germination, 
respectively. The function of the lyases AlyA1 and AlyA2 remains unknown. However, 
AlyA2 activity was shown to be essential for vegetative growth (Gimmestad et al., 2009).  
The algD gene encodes the key enzyme catalyzing the generation of the alginate monomer 
GDP-mannuronic acid (for a recent review see Galindo et al., 2007). Expression of algD is 
highly controlled by several global regulators such as the stress response sigma factor AlgU 
and the signalling transduction cascade conformed by the two-component system 
GacA/GacS and the stationary growth phase sigma factor RpoS protein, which also 
positively control PHB synthesis (Castañeda et al., 2000; 2001). A. vinelandii mutants have 
been constructed with the aim of generating alginates with different physicochemical 
properties. An algL mutant was shown to produce an alginate with a molecular mass higher 
than that of the wild type strain (Trujillo-Roldan et al., 2003). Furthermore a mutation in the 
algF gene, encoding one of the subunits of the O-acetylase complex, resulted in the 
production of a non-acetylated alginate, similar to that of algal origin (Vazquez et al., 1999). 
As the polymers PHB and alginate compete for the supplied carbon source we generated 
mutants with a total blockade in PHB synthesis and in which the production of alginate was 
increased several fold. The contrary was also true for the production of PHB as a total 
blockade in the synthesis of alginate increased the accumulation of PHB (Segura et al., 
2003b). 
5.2 Biosynthesis of PHAs by A. vinelandii 
PHB in A. vinelandii, as in most bacteria, is synthesized in three steps from acetyl-CoA 
(Figure 2; Manchak & Page 1994). ǃ-Ketothiolase catalyzes the first reaction, i.e. the 
condensation of two molecules of acetyl-CoA to form acetoacetyl-CoA. This product is 
subsequently reduced by an NADPH dependent acetoacetyl-CoA reductase to 
stereoselectively produce (R)-ǃ-hydroxybutyryl-CoA. Finally, PHB synthase catalyzes the 
polymerization of (R)-ǃ-hydroxybutyryl-CoA releasing free CoA.  
In A. vinelandii, the genes coding for these enzymes are contained in the PHB biosynthetic 
operon phbBAC, which codes for the acetoacetyl-CoA reductase, ǃ-ketothiolase, and PHB 
synthase respectively (Peralta-Gil et al., 2002; Segura et al., 2000, 2003a). In the same DNA 
region, other genes related to PHB synthesis were also found: phbR, which codes for a 
transcriptional regulator; phbP, a putative granule-associated protein; and phbF, a putative 
regulator of phbP (Peralta-Gil et al., 2002; Segura et al., 2003a). 
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When A. vinelandii UWD is grown on medium supplemented with n-alkanoates, such as 
valerate, heptanoate or nonanoate, a copolymer of poly(Hydroxybutyrate-Co-
Hydroxyvalerate) (PHBV) is synthesized (Page et al., 1992). The recent analysis of the A. 
vinelandii genome sequence (Setubal et al., 2009) demonstrated the presence of phaJ, a gene 
coding for a (D)-specific enoyl-Coenzyme A hydratase that is responsible for the channeling 
of enoyl-CoA derivatives from the fatty acid oxidation pathway to PHAs synthesis in 
several pseudomonads (Fukui et al., 1998). Thus, this enzyme would be producing the 
hydroxyvalerate precursors for PHBV synthesis in A. vinelandii (Figure 2). 
 
 
Fig. 2. Metabolic pathways involved in the synthesis of alginate and PHAs in A. vinelandii. 
PMI, phosphomannose isomerase; PMM, phosphomannose mutase; GMPP, guanosine 
diphosphomannose pyrophosphorylase; GMD, GDP-mannose dehydrogenase; MP, 
mannuronate polymerase; ED, Entner-Doudoroff pathway. 
The control of PHB biosynthesis in Azotobacter was one of the first to be studied (Senior et 
al., 1972; Senior & Dawes, 1971, 1973). The main condition triggering PHB synthesis is 
oxygen limitation, which leads to high concentrations of NADH and NADPH, that in turn 
inhibit TCA cycle enzymes, increasing the concentration of acetyl-CoA available for PHB 
biosynthesis (Manchak & Page, 1994; Senior et al., 1972; Senior & Dawes, 1973).  
The regulation of PHB synthesis in A. vinelandii is complex and additional regulatory 
systems are involved. PhbR, a regulator of the AraC family of transcriptional regulators, 
activates transcription of the phbBAC operon, and the stationary growth phase sigma factor 
RpoS is involved in the control of transcription of phbR (Peralta-Gil et al., 2002). The 
nitrogen-related phosphotransferase system (PTSNtr), formed by proteins EINtr, Npr, and 
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IIANtr regulates PHB synthesis through a phosphorelay from phosphoenolpyruvate, where 
the IIANtr protein acts as negative regulator of PHB synthesis in its non-phosphorylated 
state (Segura & Espin, 1998; Noguez et al., 2008). It has also been reported that the FNR-like 
regulatory protein called CydR (Wu et al., 2001) and the iron-regulatory small RNA named 
ArrF (Pyla et al., 2009) control PHB synthesis in response to the redox state of the cell 
(oxygen), and the availability of iron respectively. 
6. Fermentation parameters affecting the production and the composition of 
alginate 
For several decades the synthesis of alginate and PHB by A. vinelandii has been the subject of 
study, either in batch (Clementi et al., 1997; Page & Cornish 1993; Parente et al., 2000; Peña et 
al., 2000,2011; Sabra et al., 1999; Trujillo-Roldán et al., 2004), continuous (Díaz-Barrera et al., 
2009, 2010; Sabra et al., 2000), fed batch cultures (Chen & Page, 1997; Mejía et al., 2010; 
Priego-Jiménez et al., 2005) and systems with immobilized cells in membrane reactors 
(Saude & Junter, 2002). In the following sections we will describe and discuss the most 
recent advances regarding the influence of fermentation parameters, which determine the 
production and composition of alginate and PHAs. 
6.1 Influence of the dissolved oxygen tension (DOT) and the oxygen transfer rate 
(OTR) on the quantity and quality of alginate 
Many studies have shown that aeration and mixing are critical parameters for optimizing 
the production of microbial polysaccharides (Galindo et al., 2007). It is known that under 
low dissolved oxygen tension (DOT), the organism accumulates the intracellular storage 
polymer, PHB; whereas at high DOT, A. vinelandii uses the carbon source mainly for 
biomass production. Efficient conversion of sucrose to alginate is achieved only if the 
oxygen is accurately controlled between 1 and 10% of oxygen saturation (Parente et al., 2000; 
Peña et al., 2000; Sabra et al., 2000; Trujillo-Roldán et al., 2003). The DOT also affects the 
composition and molecular mass of the alginate produced by A. vinelandii. Studies in 
bioreactor, under oxygen controlled conditions (Peña et al., 2000; Sabra et al., 2001; Trujillo-
Roldán, 2004), indicate that the mean molecular mass (MMM) of the polymer, is strongly 
influenced by the DOT and the stirring speed of the culture. For example, in cultures 
conducted at low agitation speed (300 rpm) and DOT of 5 % the MMM of the polymer 
reached a maximum of 680 kDa. In contrast, at high agitation speed (700 rpm), the MMM 
increased to a plateau at low DOT (1– 3 %) and then decreased at higher DOT (5 %) (Peña et 
al., 2000). On the other hand, Sabra et al., (2000) reported that in phosphate-limited 
continuous culture, both the MM and the L-guluronic acid content increased with the DOT, 
reaching a maximal MM of 800 kDa and a guluronic acid content of 50 % in the cultures 
conducted at 10 % of air saturation. Those authors proposed that under nitrogen- fixing 
conditions, the bacterium builds a slimy layer or alginate capsule around the cells, to 
overcome the oxygen stress and to protect the nitrogenase system, causing a decrease in 
alginate biosynthesis. 
A. vinelandii is known for its high respiratory activity (Post et al., 1983) and in cultures 
without DOT control, the oxygen transfer becomes the limiting factor for growth. Without 
DOT control, the cultures operate at DOT near zero. Under this condition, a parameter that 
has been used for studying alginate production is the oxygen transfer rate (OTR). In this 
line, Díaz-Barrera et al., (2007, 2009) reported that the alginate yield and the MMM of the 
www.intechopen.com
Bioprocess Design: Fermentation Strategies for Improving  
the Production of Alginate and Poly-Hydroxyalkanoates (PHAs) by Azotobacter vinelandii 
 
227 
polymer were linked to the OTR of the culture. They found that the MMM of the alginate 
increased as OTRmax decreased, observing that the MMM obtained at 3.0 mmol L-1 h-1 was 
7.0 times higher (1560 kDa) than at 9.0 mmol L-1 h-1 (220 kDa; Figure 3). It is important to 
quote that in previous reports the cultures were oxygen limited and under such conditions 
the carbon source was only partially oxidized, which forced the cells to follow anaerobic 
pathways with the consequent production of PHB.  
More recently, Lozano et al., (2011) reported a study about the evolution of the MMM of the 
alginate produced by A. vinelandii ATCC 9046 in terms of the maximum oxygen transfer rate 
(OTRmax) in cultures where the dissolved oxygen tension (DOT) was kept constant. An 
increase in the agitation rate (from 300 to 700 rpm) caused a significant increase in the 
OTRmax (from 17 to 100 mmol L-1 h-1 for DOT of 5 %, and from 6 to 70 mmol L-1 h-1 for DOT 
of 0.5 %). This increase in the OTRmax improved alginate production, as well as the specific 
alginate production rate. In contrast, the mean molecular mass (MMM) of the alginate 
isolated from cultures developed under non-oxygen limited conditions increased by 
decreasing the OTRmax, reaching a maximum of 550 kDa at an OTRmax of 17 mmol L-1 h-1 . 
However, in the cultures developed under oxygen limitation (0.5 % DOT), the MMM of the 
polymer was practically the same (around 200 kDa) at 300 and 700 rpm and it remained 
constant throughout the cultivation (Lozano et al., 2011).  
 
 
Fig. 3. Mean molecular mass of alginate as a function of the oxygen transfer rate in cultures 
of A. vinelandii in shake flasks and stirred fermentor. 
6.2 Influence of the medium components  
It is widely known that the components of the culture medium play an important role in the 
production of alginate by A. vinelandii. Most studies have focused on assessing the influence 
of calcium, phosphate and nitrogen on alginate yield and its molecular mass (MM) (Parente 
et al., 2000; Sabra et al. 1999). Sabra et al., (1999) found that an excess of phosphate in the 
culture medium (400 mg L-1) caused a decrease in alginate yield. In the case of nitrogen the 
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results reported are contradictory, probably because the strain and medium composition 
used were different (Clementi, 1997; Sabra et al., 2001). Recently, Zapata-Vélez & Trujillo-
Roldán (2010) reported that in cultures of A. vinelandii in shake flasks, the best nitrogen 
sources for alginate production were peptone, tryptone, and yeast extract, yielding a 
maximal alginate concentration of 4.0±0.4 g L-1. Those authors found that the highest MMM 
was obtained in cultures grown with peptone (1,520 ± 110 kDa), whereas cultures grown 
with yeast extract, tryptone, ammonium acetate, and ammonium sulphate, showed values 
between 1,400 and 1,100 kDa. On the other hand, a lower MMM was obtained under N2-
fixing conditions (625 ± 110 kDa).  
Our group reported the influence of (3N-morpholino)-propane-sulfonic acid (MOPS), a 
component used in the medium to keep a constant pH, on the quality of the alginate in 
terms of the chemical composition and rheological behaviour of alginate-reconstituted 
solutions (Peña et al., 2006). This compound had an important effect on the acetyl content 
and physicochemical properties of this polymer. A two-fold higher acetylation degree of 
alginate was obtained when 13.6 mM MOPS was supplemented to the medium. The higher 
acetylation resulted in greater viscosity of the alginate solutions, but it exhibited less 
pronounced pseudoplastic behaviour. These changes in the functional properties of the 
polymer can have great value in terms of specific applications of alginate in food and 
pharmaceutical fields. 
6.3 Effect of the specific growth rate 
Another important culture parameter for the synthesis of alginate is the specific growth rate 
(Díaz-Barrera et al., 2009, 2010; Priego-Jiménez et al., 2005). Priego-Jiménez et al., (2005) 
using exponentially fed-batch cultures, found that the specific growth rate of A. vinelandii 
negatively affects the MM of the alginate and to some extent, the alginate/biomass and 
alginate/sucrose ratio. This effect was particularly pronounced at very low specific growth 
rates (0.03 h-1), where the YP/X, YP/S and the MMM were up to 2.3, 10 and 14 times higher, 
respectively, than those obtained at a specific growth rate of 0.21 h-1 (the value found in 
conventional batch cultures). More recently, Díaz-Barrera et al., (2010) reported, in 
chemostat cultures, that the alginate MM increased from 800 to 1800 kDa when the dilution 
rate increased from 0.05 to 0.1 h-1 at a low inlet sucrose concentration (5 g L-1). In contrast, at 
high sucrose concentration, the MM increased from 1230 to 2500 kDa when the dilution rate, 
and therefore, the specific growth rate were decreased in the same range. According to the 
authors, this behaviour is linked to changes in the specific sucrose uptake rate (Díaz-Barrera 
et al., 2010). 
7. Parameters that affect PHAs production in A. vinelandii 
Commercial production of PHAs requires not only high yields and productivities, but also a 
well defined chemical composition. Fermentation parameters affect the amount of PHAs 
produced by Azotobacter, and their chemical characteristics, such as the kind of polymer 
produced (PHB homopolymer or PHBV heteropolymer); the MM; and finally, the monomer 
ratio and distribution along the PHA heteropolymer chain.  
PHAs production in different organisms is induced under nutrient limitation (Verlinden et 
al., 2007). For Azotobacter species, oxygen limitation is the most efficient way to induce PHB 
production (Galindo et al., 2007; Senior & Dawes, 1971, 1973; Verlinden et al., 2007). Besides 
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oxygen limitation, changes in the carbon and nitrogen sources can affect PHB biosynthesis 
by Azotobacter (Myshkina et al., 2008; Page, 1992). Also, the addition of alkanoates to the 
medium allows the synthesis of PHAs with different monomer composition (Myshkina et 
al., 2010; Page et al., 1992). 
7.1 Oxygen limitation  
When Azotobacter grows under oxygen limitation there is a reduction in the activity of the 
tricarboxylic acid cycle (TCA), and the molecules of acetyl-CoA are channeled to PHB 
production, and the synthesis of PHB acts like an electron sink (Page & Knosp, 1989; Senior 
et al., 1972). The positive effect of oxygen limitation on PHB production (based on yield and 
PHB content), has been reported for A. vinelandii in batch cultures, using wild type strains 
UW (Page & Knosp, 1989) and ATCC9046 (Peña et al., 2011), and the PHB overproducer 
mutant strain UWD (Page & Knosp, 1989). Changes in oxygen concentration have been 
successfully used in fed batch cultures of A. vinelandii UWD (Chen & Page, 1997; Page et al., 
2001). Chen & Page (1997), enhanced biomass production of this strain using high aeration 
during the first stage of the culture and then, at the second stage, aeration was lowered, 
promoting PHB formation. At the end of the culture, PHB concentration reached 36 g L-1 of 
PHB, in contrast to 25 g L-1 of PHB reported by Page & Cornish (1993) in fed-batch cultures 
without aeration changes.  
On the other hand, there are few reports related to the effect of oxygen on the composition 
of the PHB produced by Azotobacter. Quagliano & Miyazaki (1997) observed in 
fermentations of A. chroococcum 6B that changes in the aeration rate from 0.5 to 2.5 vvm 
could negatively impact the molecular weight of the PHB with a 10 fold decrease from 1100 
to 111 kDa. Myshkina et al., (2008) observed, in cultures of A. chroococcum 7B in shake flasks, 
that the MM increased from 1480 to 1670 kDa when the agitation rate decreased from 250 to 
190 rpm. In contrast, the yields of PHB (YPHB/Biomass) at both agitation rates were the same 
(0.75 g PHB g-1biomass). These authors also evaluated the effect of strict microaerobic and 
anaerobic conditions during stationary phase, on PHB yield and on its MM. Under these 
conditions, the PHB content decreased to 2.6 and 1.7 g L-1, respectively, but the MM 
increased, reaching 2215 kDa at the strict anaerobic condition (Myshkina et al., 2008).  
7.2 Medium composition: carbon and nitrogen sources 
The high production cost is the main limiting factor for the use of PHAs for commercial 
purposes. An alternative to reduce costs is the use of cheaper feedstock (Page, 1992). Several 
attempts have been made to improve the culture media composition which depends on the 
microorganism (Table 2). Although Azotobacter is a nitrogen fixing bacteria, addition of a 
fixed nitrogen source can improve PHAs production. Quagliano & Miyasaki (1997), found 
that increasing the C:N ratio improved PHB yields, although the MM of the polymer 
dropped eight fold. Page & Cornish (1993) observed that organic nitrogen sources like fish 
peptone improved PHB production. In addition to the use of low cost nitrogen sources, the 
use of low price carbon sources is a good alternative to reduce production costs (Page, 1992; 
Verlinden et al., 2007). Page (1992) found that in shake flasks cultures the addition of 0.5 % 
(P/V) of beet molasses, increased the PHAs content in A. vinelandii UWD to 7 g L-1, in 
contrast to the 1 g L-1 obtained when using sucrose at 2%(P/V) as a sole carbon source. 
Although beet molasses were the best carbon source, this strain was also able to grow and 
produce PHAs using cane molasses, malt extract or corn syrup. However, Myshkina et al., 
(2008) observed that for A. chroococcum 7B, molasses did not improve growth or PHB 
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production, while the best PHB yields were obtained with commercial sugar and vinasses. 
These authors also reported that the MM of the PHB could be affected by the carbon source, 
reaching the highest MM when using glucose, food sugar or starch (1660, 1490 and 1310 
kDa).  
 
Strain Carbon 
source 
Nitrogen 
source 
PHB (gL-1) YP/S Mw 
(kDa)
Type of 
culture 
Referenc
e 
A. 
vinelandii 
UWD 
Glucose (1%) 
and acetate 
(15mM) 
NH4+ 2.37 0.25 N.D Flasks Page & 
Knosp, 
1989 
A. 
vinelandii 
UWD 
Beet 
Molasses 
(5%) and 
sucrose (2%)
NH4+ 7 0.35 N.D Flasks Page, 1992 
A. 
vinelandii 
UWD 
Glucose (5%)
acetate 
(15mM) 
NH4+ 
Fish peptone 
(1%) 
25 0.65 1700 Fed batch 
culture 
Page & 
Cornish, 
1993 
A. 
chroococcum 
7B 
Glucose (4%) ----- 4 0.1 1660 Flasks Myshkina 
et al., 2008 
A. 
chroococcum  
7B 
Glucose (2%)
Acetate 
(20mM) 
----- 4 0.2 1100 Flasks Myshkina 
et al., 2008 
A. 
chroococcum 
7B 
Molasses 
(4%) 
Sucrose (2%)
----- 1 0.05 N.D. Flasks Myshkina 
et al., 2008 
Table 2. PHB production by Azotobacter grown with different sources of carbon and 
nitrogen. 
7.3 Addition of alkanoates  
For several Azotobacter spp., the addition of alkanoates to the growth media for PHAs 
production allows the synthesis of polymers with specific composition (Durner et al., 2000; 
Gónzalez-López et al., 1996; Myshkina et al., 2010; Page et al., 1992; Sun et al., 2007; Zinn et 
al., 2003). The effect of alkanoates addition is dependent on the strain and its metabolism. In 
cultures of A. vinelandii UWD, the addition of odd alkanoates (C5-C9) allowed the 
biosynthesis of the copolymer PHBV. Although there was copolymer production using the 
three different substrates (valerate, heptanoate and nonaoate), the highest proportion of HV 
was achieved with valerate (Page et al., 1992). 
For A. chroococcum the biosynthesis of PHBV by addition of not only five carbon valeric acid 
but of other organic acids (propanoic and hexanoic), was reported. However the best yields 
and the highest HV content were obtained with valerate (Myshkina et al., 2010). The 
addition of alkanoates with more than five carbons to Azotobacter cultures did not allow 
biosynthesis of hydroxyalkanoates of a higher monomer chain length (Myshkina et., al 2010; 
Page et al., 1992). Although Azotobacter and Pseudomonas are genetically related (Setubal et 
al., 2009), the PHAs metabolism in Azotobacter differs completely from that observed in most 
Pseudomonas species which are efficient producers of mcl-PHAs (Durner et al., 2000; 
Hartmann et al., 2005; Sun et al., 2007). However, the close genetic relationship between 
Pseudomonas and A. vinelandii could be useful for genetic improvement of A. vinelandii 
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strains for the biosynthesis of mcl-PHAs, as has been successfully reported for E. coli (Sun et 
al., 2007; Verlinden et al., 2007). 
8. Scaling up of alginate and PHAs production 
Trying to reproduce in agitated tank the results obtained in plates or in shake flasks, is 
troublesome and the variables involved are poorly understood. This is particularly 
important, because the MM of the polymer drops dramatically when the alginate process is 
scaled up from shake flasks to fermentors (Peña et al., 1997, 2000). Both, the power input 
(P/V) and the oxygen transfer rate (OTR), have been used as scaling up parameters (Peña et 
al., 2008; Reyes et al., 2003). Recently, our group has studied both the evolution of the 
specific power consumption and oxygen transfer rate, occurring in shake flasks cultures of 
A. vinelandii (Peña et al., 2007).  
These studies have revealed that the power consumption increased exponentially during the 
course of the fermentation (up to 1.4 kW m-3) due to an increase in the viscosity of the 
culture broth. Taking these data as a starting point, a scale-up strategy based on the 
evolution of the power input observed in shake flasks has been evaluated, trying to 
reproduce in a stirred fermentor culture the MMM of the alginates obtained in shake flasks 
(Peña et al., 2008). Simulating the evolution of the power input in 14 L fermentors, allowed 
us to reproduce the MMM and molecular mass distributions of the alginate obtained in 
shake flasks (Figure 4), a situation that had not been possible to achieve before using other 
criteria (i.e., initial power input (Reyes et al., 2003)). 
 
 
Fig. 4. Scaling-up of alginate production using the evolution of power input as a criterion. 
Currently PHAs bacterial production, at industrial scale, is mainly conducted using the 
strain C. necator, until now the most cost-effective fermentative process for the copolymer 
PHBV (Verlinden, 2007; Wang et al., 2011). In addition, several species of Pseudomonas have 
been described as potential producers of mcl-PHAs (Durner et al., 2000; Hartmann et al., 
2005; Sun et al., 2007; Wang et al., 2011). For both fermentation processes the scaling up 
strategies have focused not only on increasing biomass and polymer content using low cost 
feedstock, but also on improving chemical properties of the biopolymer. The main strategies 
proposed in this line are related to the use of fed batch and continuous cultures (Sun et al., 
2007; Verlinden et al., 2007;). The PHAs production is usually operated as fed batch cultures, 
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with an initial growth phase in rich medium in order to obtain a high cell density culture, 
followed by a product accumulation phase usually under substrate limiting conditions 
(Verlinden et al. 2007; Sun et al., 2007). It is worthy to point out that for fed batch 
cultivations it is important to define the composition of the media used for starting the 
culture, the feeding composition, the type of limitation used for inducing PHA synthesis, 
and the time at which the feeding should be started. The adequate selection of these 
parameters can improve the yields and composition of the PHA produced. 
Fed batch cultures of A. vinelandii UWD using beet molasses have successfully improved 
PHAs content from 7 g L-1 obtained in flasks, to up to 25-36 g L-1 in fed batch cultures, 
reaching a maximum yield of 0.65 g PHA g-1Carbon source (Chen & Page, 1997; Page et al., 2001). 
Continuous fermentation is an alternative to increase PHAs productivity (Sun et al., 2007). 
These fermentations have been successfully used to improve mcl-PHAs production 
parameters with Pseudomonas (Sun et al., 2007) and scl-PHAs with C. necator (Zinn et al., 
2003). Using C. necator DSM 428, Zinn et al., (2003) evaluated the PHBV copolymer 
production under dual (C,N) limitation in chemostat cultures, obtaining controlled 
composition of the polymer in the range of 0-62 mol % HV. The cultivations in chemostat 
allowed a constant production of PHB/HV and an accurate control of the polymer 
composition. 
In the case of mcl-PHAs production, Hartmann et al., (2005) evaluated chemostat cultures of 
Pseudomonas putida GPo1 under dual (C, N) limitation. They found, that the monomeric 
composition of mcl-PHAs was independent of the C:N ratio in the feed media, but it was 
dependent on the dilution rate. They also found that at low dilution rates, the fraction of 
aliphatic monomers in the mcl-PHAs was slightly higher than at high dilution rates. 
9. Design of novel processes to improve alginate and PHA production 
Alginate production by fermentation using the A. vinelandii bacterium could be a feasible 
strategy; however, polymer concentrations in batch cultures reported so far are very low, 
with maximum concentrations of alginate in the range of 3–5 g L-1 (Parente et al., 2000; Peña 
et al., 2000; Sabra et al., 2000). It is important to point out that the final alginate 
concentration is the most important parameter in determining the economics of the process, 
as it is related to the recovery cost, especially during the precipitation step (Peña et al., 2008). 
Several fermentation strategies have been reported in the literature with the aim of 
improving the quantity and/or quality of the alginate (Asami et al., 2004; Cheze-Lange et 
al., 2002; Mejia et al., 2010; Saude & Junter, 2002). For example, Cheze-Lange et al., (2002) 
reported the advantages of continuous production of bacterial alginate by A. vinelandii, 
coupled to a system of membranes of varying nominal pore sizes. According to these 
authors, the yields of alginate with respect to sucrose were significantly higher compared to 
the batch process. However, the MM of the polymer and the polydispersity were very 
similar to those of the alginate obtained from batch experiments. Asami et al., (2004) found 
that the productivity and the fraction of GG-blocks of the alginate produced by A. vinelandii 
in a bubble column were higher than those obtained in shake flasks. They observed that the 
production of GG-blocks in the late exponential growth phase was higher than that obtained 
in the stationary phase. However, the authors did not explain the reasons for the difference 
in the fraction of GG blocks under varying conditions.  
Our research group has carried out studies in fed-batch and multistage fermentation 
processes (Mejía et al., 2010; Priego-Jiménez et al., 2005) that are able to achieve high 
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biomass concentration, in order to take advantage of the higher specific-alginate production 
capacities of mutant such as the AT6 strain. Employing a high oxygen concentration (10%) 
allowed obtaining a maximum biomass concentration of 7.5 g L-1 in the first stage of the 
cultivation. In the second stage, the cultures were limited by oxygen (oxygen close to 0%) 
and fed with a sucrose solution at high concentration. Under those conditions, the growth 
rate decreased considerably and the cells used the carbon source mainly for alginate 
biosynthesis, obtaining a maximum concentration of 9.5 g L-1, after 50 h of cultivation. 
Alginate concentration obtained from the AT6 strain was two fold higher than that obtained 
using the wild-type strain (ATCC 9046) and was the highest reported in the literature (Mejía 
et al., 2010).  
Most of the studies using Azotobacter spp. for PHA production have been implemented 
using batch cultures. Because PHAs are intracellular products and their synthesis occurs 
under growth limiting conditions, like oxygen limitation, fed-batch fermentation or 
multistage cultures have been the methods used to achieve high cell densities containing the 
highest possible amount of PHA with several PHA producers (Akaraonye et al., 2010). On 
the other hand, continuous cultivation is an interesting alternative strategy because a high 
productivity can be reached, especially for strains with a high specific growth rate 
(Akaraonye et al., 2010). However, it is difficult to balance biomass concentration, PHAs 
content and productivity, because changes in the dilution rate can have opposite effects on 
cell growth and PHAs synthesis. This is due to the requirement for a nutrient limitation to 
induce polymer synthesis, at growth rates below the maximum specific growth rate. The 
ability to produce PHAs under non limiting growth conditions of some A. vinelandii strain 
could represent an advantage to establish continuous culture processes (Page & Knosp, 
1989).  
Two-stage continuous cultures can help establishing a good growth/PHAs synthesis 
compromise. Jung et al., (2001) used a two-stage continuous cultivation system with two 
fermentors connected in series, producing cells at a specific growth rate in the first 
compartment, and establishing conditions to accumulate PHA at higher rates in a second 
compartment, with a relatively long residence time. Dilution rates of 0.21 h−1 in the first 
fermentor and 0.16 h−1 in the second fermentor yielded a volumetric PHAs productivity of 
0.06 gPHA L−1 h−1, a high productivity for cultures grown on alkanes. 
Processes using cheaper substrates have the potential to lower the production costs of PHAs 
production, but for the use of some of these substrates additional processing is needed. 
Cerrone et al., (2010) reported an interesting strategy to simultaneously produce PHB and 
treat olive mil wastewater using A. vinelandii UWD, A. vinelandii ATCC 12387, or A. 
chroococcum. It consisted on a phase of anaerobic digestion of the olive mil wastewater 
during 27 h, in order to produce short-chain fatty acids, to later inoculate the Azotobacter 
strains for the aerobic PHA producing stage. Similar strategies could be implemented for the 
utilization of other agro-industrial residues allowing the use of cheap substrates and 
additionally reducing costs by linking PHA production with waste disposal processes. 
10. Down stream processes 
Alginate and PHAs have been proposed for novel applications in pharmaceutical and 
biomedical fields. However, for these applications it is necessary to ensure products with a 
high purity, and in most cases with a defined chemical composition. Chemical composition 
of these polymers can be controlled by the fermentation stage, but their purity will be 
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determined by the down stream processing. Moreover, costs and efficiency of purification 
procedures could affect the whole process feasibility.  
The extraction process of alginate from Azotobacter, starts with the supernatant recovery 
from the fermentation broth by centrifugation. Afterwards, the supernatant is treated with 
NaCl2, followed by an acidification-hydration step, and finally it is precipitated with 
isopropanol. This final product could be dried and milled (Sabra & Zeng, 2009). However, 
alginates for applications in the biomedical and pharmaceutical fields need to be non-
immunogenic, and this extraction process does not ensure a high purity of the product. The 
immunogenic response could be due to the presence of polyphenols, endotoxins or proteins 
(Ménard et al., 2010). With the purpose of removing these impurities Ménard et al., (2010) 
proposed the introduction of size exclusion chromatography (SEC). Using this method, the 
authors observed a reduction of up to 90 % of residual protein contaminants in commercial 
alginate and therefore a decrease in the immunogenicity of the alginate beads prepared. 
Once that alginate is purified, it could be modified to enhance or change its physicochemical 
properties, by either chemical (Yang et al., 2011) or enzymatic methods (Morch et al., 2008). 
Alginate downstream modifications could include, acetylation, addition of aminoacids 
and/or proteins, deacetylation, epimerization, oxidation, sulfation and copolymerization. 
The PHAs extraction processes require the separation of the cells containing the polymer by 
centrifugation. The recovery of intracellular PHAs could be carried out by solvent extraction 
using acetone, chloroform, methylene chloride or dichloroethane. Although this method is 
the most used, it is also expensive and environmentally unfriendly (Verlinden et al., 2007; 
Yasotha et al., 2006). Besides, several alternative methods have been developed to improve 
PHAs purification. Enzymatic digestion does not need hazardous solvents and it shows 
high selectivity. Yasotha et al., (2006) proposed an enzymatic method coupled to an 
ultrafiltration system and achieved a final PHAs purity of 92.6 % with a recovery of almost 
90 %. However, this method could be very expensive. Another interesting alternative for 
PHAs recovery was proposed by Page & Cornish (1993), using fish peptone like nitrogen 
source for the growth of A. vinelandii. Fish peptone enhanced PHB production and led to the 
production of pleomorphic and osmotically sensitive cells. They took advantage of this cell 
fragility to simplify PHAs extraction method using NH4OH at 45ºC. With this method PHB 
was recovered with a 94% of purity. Finally, Hejazi et al., (2003), developed a method based 
on supercritical fluid disruption of the cells using supercritical CO2 at 200 atm, with a PHB 
recovery of 89%. Although this method also uses organic solvents, it requires less than the 
traditional extraction method. 
11. Conclusions  
Based on a better understanding of the biosynthesis and regulation of alginate and PHAs in 
A. vinelandii, as well as on the development of new cell culture systems for biopolymers 
production, it is possible to propose new fermentation strategies to obtain alginate and 
PHAs with specific chemical characteristics and more defined material properties. These 
materials could be used in specific applications in pharmaceutical and biomedical fields. In 
summary, this chapter has shown that the use of a multidisciplinary approach, integrating 
molecular and bioengineering aspects, would allow the optimization of both alginate and 
PHAs production using A. vinelandii. 
www.intechopen.com
Bioprocess Design: Fermentation Strategies for Improving  
the Production of Alginate and Poly-Hydroxyalkanoates (PHAs) by Azotobacter vinelandii 
 
235 
12. Acknowledgment  
Financial support of DGAPA-UNAM (grants IN218201, IN216700, and IN221809) and 
CONACyT (grant 57220, 101643 and 127979) is gratefully acknowledged. The authors 
acknowledge R. Rodríguez Bahena for his assistance on computer support. 
13. References  
Akaraonye, E.; Keshavarz, T. & Roy, I. (2010). Production of polyhydroxyalkanoates: the 
future Green materials of choice. Journal of Chemical Technology and Biotechnology, 85, 
732-743. 
Aldor, I. & Keasling, J. (2003). Process design for microbial plastic factories: metabolic 
engineering of polyhydroxyalkanoates. Current Opinion on Biotechnology, 14, 475-
483.  
Asami, K.; Aritomi, T.; Tan, Y. & Ohtaguchi, K. (2004). Biosynthesis of polysaccharide 
alginate by Azotobacter vinelandii in a bubble column. Journal of Chemical Engineering 
Japan, 37, 1050-1055. 
Augst, A.; Joon-Kong, H. & Mooney, D. (2006). Alginate hydrogels as biomaterials. 
Macromolecular Bioscience, 6, 623-633. 
Banki, M.; Gerngross, T. & Wood, D. (2005). Novel and economical purification of 
recombinant proteins: Intein-mediated protein purification using in vivo 
polyhydroxybutyrate (PHB) matrix association. Protein Sciences, 14(6), 1387–1395. 
Barnard, G.; McCool, J.; Wood, D. & Gerngross, T. (2005). Integrated recombinant protein 
expression and purification platform based on Ralstonia eutropha. Applied and 
Environmental Microbiolology, 71, 5735–5742. 
Brockelbank, J.; Peters, V. & Rehm, B. (2006). Recombinant Escherichia coli strain produces a 
ZZ domain displaying biopolyester granules suitable for Immunoglobulin G 
purification. Applied and Environmental Microbiology, 72(11), 7394–7397. 
Campos, M.; Martinez-Salazar, J.; Lloret, L.; Moreno, S.; Núñez, C.; Espín, G. & Soberon-
Chávez, G. (1996). Characterization of the gene coding for GDP-mannose 
dehydrogenase (algD) from Azotobacter vinelandii. Journal of Bacteriology, 178, 1793-
1799. 
Castañeda, M.; Guzmán, J.; Moreno, S. & Espin, G. (2000). The GacS sensor kinase regulates 
alginate and poly-beta-hydroxybutyrate production in Azotobacter vinelandii. Journal 
of Bacteriology, 182, 2624-2628. 
Castañeda, M.; Sanchez, J.; Moreno, S.; Nunez, C. & Espin, G. (2001). The global regulators 
GacA and sigma(S) form part of a cascade that controls alginate production in 
Azotobacter vinelandii. Journal of Bacteriology, 183, 6787-6793. 
Cerrone, F.; Sánchez-Peinado, M.; Juárez-Jiménez, B.; González-López, J. & Pozo, C. (2010). 
Biological teatment of two-phase olive mil wastewater (TPOMW, alpeorujo): 
Polyhydroxyalkanoates (PHAs) production by Azotobacter strains. Journal of 
Microbiology and Biotechnology, 20, 594-601. 
Chen, G. & Page, W. (1997). Production of poly-ǃ-hydroxybutyrate by Azotobacter vinelandii 
in a two-stage fermentation process. Biotechnology Technology, 11, 347-350. 
Chen, G. & Wu, Q. (2005). The application of polyhydroxyalkanoates as tissue engineering 
materials. Biomaterials, 26, 6565–6578. 
www.intechopen.com
Progress in Molecular and Environmental Bioengineering  
– From Analysis and Modeling to Technology Applications 
 
236 
Chen, G. (2009). A microbial polyhydroxyalkanoates (PHA) based bio-and materials 
industry. Chemistry Society Reviews, 38, 2434–2446. 
Cheze-Lange, H.; Beunard, D.; Dhulster, P.; Guillochon, D.; Caze, A.; Morcellet, M.; Saude, 
N. & Junter.; G. (2002). Production of microbial alginate in a membrane bioreactor. 
Enzyme Microbiology Technology, 30, 656-661. 
Clementi, F. (1997). Alginate production by Azotobacter vinelandii. Critical Reviews in 
Biotechnology, 17, 327-361. 
Conway, T. (1992). The Entner-Doudoroff pathway: History, physiology and molecular 
biology. FEMS Microbiology Reviews, 9, 1-27. 
Díaz-Barrera, A.; Peña, C. & Galindo, E. (2007). The oxygen transfer rate influences the 
molecular mass of the alginate produced by Azotobacter vinelandii. Applied 
Microbiology Biotechnology, 76, 903-910. 
Díaz-Barrera, A.; Silva, P.; Ávalos, R. & Acevedo, F. (2009). Alginate molecular mass 
produced by Azotobacter vinelandii in response to changes of the O2 transfer rate in 
chemostat cultures. Biotechnology Letters, 31, 825-829. 
Díaz Barrera, A.; Silva, P.; Berrios, J. & Acevedo, F. (2010). Manipulating the molecular 
weight of the alginate produced by Azotobacter vinelandii in continuous cultures. 
Bioresource Technology, 101, 9405-08. 
Donnan, F. & Rose, R. (1950). Osmotic pressure, molecular weight, and viscosity of sodium 
alginate. Canadian Journal Research, 28 (B), 105-113. 
Dörig, G. & Pier G. (2008). Vaccines and immunotherapy against Pseudomonas aeruginosa, 
Vaccine, 26, 1011-1024. 
Draget, I. & Taylor, C. (2011). Chemical, physical and biological properties of alginates and 
their biomedical implications. Food Hydrocolloids, 25, 251-256. 
Durner, R. ; Witholt, B. & Egli, T. (2000). Accumulation of Poly R-ǃ-Hydroxyalkanoates in 
Pseudomonas oleovorans during growth with octanoate in continuous culture at 
different dilution rates, Applied and Environmental Microbiology, 66(8), 3408-3414. 
Ertesvag, H.; Hoidal, H.; Schjerven, H.; Svanem, B. & Valla, S. (1999). Mannuronan C-5 
epimerases and their application for in vitro and in vivo design of new alginates 
useful in biotechnology. Metabolic Engineering, 1, 262-269. 
Freier, T. (2006). Biopolyesters in Tissue Engineering Applications. Advances in Polymer 
Science. 203, 1-61. 
Fukui, T.; N. Shiomi, & Y. Doi. (1998). Expression and characterization of (R)-specific enoyl 
coenzyme A hydratase involved in polyhydroxyalkanoate biosynthesis by 
Aeromonas caviae. Journal of Bacteriology, 180, 667–673. 
Galindo, E.; Peña, C. ; Núñez, C. ; Segura, D. & Espin, G. (2007). Molecular and 
bioengineering strategies to improve alginate and polyhydroxyalkanoate 
production by Azotobacter vinelandii. Microbial Cell Factories, 6, 1-16. 
Gimmestad, M.; Ertesvag, H.; Heggeset, T.;Aarstad, O.; Svanem, B. & Valla, S. (2009). 
Characterization of three new Azotobacter vinelandii alginate lyases, one of which is 
involved in cyst germination. Journal of Bacteriology, 191, 4845-4853. 
González-López, J. ; Pozo, C. ; Martínez-Toledo, M. ; Rodelas, B. & Salmeron, V. (1996). 
Production of polyhydroxyalkanoates  by Azotobacter chroococcum H23 in wasteater 
from olive oil mills (Alpechin), International Biodeterioration and Biodegradation, 38 (3-
4), 271-276. 
www.intechopen.com
Bioprocess Design: Fermentation Strategies for Improving  
the Production of Alginate and Poly-Hydroxyalkanoates (PHAs) by Azotobacter vinelandii 
 
237 
Grage, K.; Jahns, A.; Parlane, N.; Palanisamy, R.; Rasiah, I.; Atwood, J. & Rehm B. (2009). 
Bacterial polyhydroxyalkanoate granules: biogenesis, structure, and potential use 
as nano-/micro-Beads in biotechnological and biomedical applications. 
Biomacromolecules, 10, 660–669. 
Grant, G.; Morris, E.; Rees, D.; Smith, P.; & Thom, D. (1973). Biological interactions between 
polysaccharide and divalent cations: the egg box model. FEBS Letters, 32, 195-198. 
Hartmann, R. ; Hany, R. ; Pletscher, E. ; Ritter, A. ; Witholt, B. & Zinn M. (2005). Tailor-made 
olefinic medium chain lenght poly R-hydroxyalkanoates by Pseudomonas putida 
Gpo1 : Batch versus chemostat production, Biotechnology and Bioengineering, 93 (4), 
737-746. 
Hejazi, P. ; Vasheghani-Farahani, E. & Yamini, Y. (2003). Supercritical fluid disruption of 
Ralstonia eutrofa for Poly-ǃ-Hydroxybutyrate recovery, Biotechnology Progress, 19, 
1519-1523. 
Hernández R. ; Orive G. ; Murua A. ; & Pedraz J. (2010). Microcapsules and microcarriers for 
in situ cell delivery, Advanced Drug Delivery Reviews, 62 (7-8), 711-730. 
Hoesli, C. ; Raghuram, K. ; Kiang, R. ; Mocinecová, D. ; Hu, X.L ; Johnson, J. ; Lacík, I. ; 
Kieffer, T. & Piret, J. (2011). Pancreatic cell immobilization in alginate beads 
produced by emulsion and internal gelation, Biotechnology and Bioengineering, 
108 (2), 424-434. 
Hori, Y.; Winans, A.; Huang, C.; Horrigan, E. & Irvine, D. (2008), Injectable dendritic cell-
carrying alginate gels for immunization and immunotherapy. Biomaterials, 29, 3671-
3682. 
Hori, Y.; Stern, P. J.; Hynes, R. & Darrell, J. (2009). Engulfing tumors with synthetic 
extracellular matrices for cancer immunotherapy. Biomaterials, 30 (35), 6757-6767. 
Jahns, A.; Haverkamp, R. & Rehm, B. (2008). Multifunctional Inorganic-Binding Beads Self-
Assembled Inside Engineered Bacteria. Bioconjugate Chemistry, 19 (10), 2072–2080. 
Jung, K.; Hazenberg, W.; Prieto, M. & Witholt, B. (2001). Two-stage continuous process 
development for the production of medium-chain-length poly(3-
hydroxyalkanoates). Biotechnology and Bioengineering, 72, 19-24. 
Kashef, N.; Behzadian-Nejad, Q.; Najar-Peerayeh, S.; Mousavi-Hosseini, K.; Moazzeni, M. & 
Gholamreza E. (2006). Synthesis and characterization of Pseudomonas aeruginosa 
alginate-tetanus toxoid conjugate. Journal of Medical Microbiology, 55, 1441-1446. 
Kennedy, C.; Rudnick, P.; MacDonald, T.; & Melton, T. (2005). Genus Azotobacter. In: Bergey´s 
Manual of Systematic Bacteriology, G. M. Garrita, 384-401, vol. 2 part B, Springer-
Verlag, New York, NY. 
Khanna, S. & Srivastava, A. (2005). Recent advances in microbial polyhydroxyalkanoates. 
Process Biochemistry, 40, 607–619. 
Lee S. (1996). Bacterial Polyhydroxyalkanoates. Biotechnology and Bioengineering 49, 1-14. 
Lee, S.; Park, J.; Park, T.; Lee, S.; Lee, S. & Park, J. K. (2005). Selective Immobilization of 
Fusion Proteins on Poly(hydroxyalkanoate) Microbeads. Analytical Chemistry, 77, 
5755–5759. 
Lozano, E.; Galindo, E. & Peña, C. (2011). The quantity and molecular mass of the alginate 
produced by Azotobacter vinelandii under oxygen-limited and non oxygen-limited 
conditions are determined by the maximal oxygen transfer rate (OTRmax). Microbial 
Cell Factories, 10, 1-13.  
www.intechopen.com
Progress in Molecular and Environmental Bioengineering  
– From Analysis and Modeling to Technology Applications 
 
238 
Ludwig, B.; Zimmerman, B.; Steffen, A.; Yavriants, K.; Azarov, D.; Reichel, A.; Vardi, P.; 
Grman, T.; Shabtay, N.; Rote, A.; Evron, Y., Neufeld, T.; Mimon, S.; Ludwig, S.; 
Brendel, M.; Bornstein, S. & Barkai, U. (2010). A novel device for islet 
transplantation providing immune protection and oxygen supply. Hormone 
Metabolism Research, 42, 918-922. 
Lynn, A. & Hassid, W. (1966). Pathway of alginic acid synthesis in the marine brown alga, 
Fucus gardneri Silva. Journal of Biological Chemistry, 241, 5284-5297. 
Madison, L. & Huisman, G. (1999). Metabolic Engineering of Poly(3-Hydroxyalkanoates): 
From DNA to Plastic. Microbiology and Molecular Biology Reviews, 63(1), 21-53. 
Manchak, J. & Page, W. (1994). Control of polyhydroxyalkanoates synthesis in Azotobacter 
vinelandii strain UWD. Microbiology, 140, 953-963. 
Mee, C.; Banki, M. & Wood, D. (2008). Towards the elimination of chromatography in 
protein purification: Expressing proteins engineered to purify themselves. Chemical 
Engineering Journal, 135 (1-2), 56-62. 
Mejía, M.; Segura, D.; Espín, G.; Galindo, E. & Peña, C. (2010). Two stage fermentation 
process for alginate production by Azotobacter vinelandii mutant altered in poly-- 
hydroxybutyrate (PHB) synthesis. Journal of Applied Microbiology, 108, 55-61. 
Ménard, M.; Dusseault, J.; Langlois, G.; Baille, W.; Tam, S.; Yahia, L.; Zhu, X.; & Hallé, J-P. 
(2010). Role of protein contaminants in the inmmunogenicity of alginates. Journal of 
Biomedical Materials Research part B: Applied Biomaterials, DOI:10.1002/jbm.b.31570. 
Morch, Y.; Holtan, S.; Donatti, I.; Strand, B. & Skjak-Braek. (2008). Mechanichal properties of 
C-5 epimerized alginates. Biomacromolecules, 9, 2360-2368. 
Myshkina, V.; Nikolaeva, D.; Makhina, T.; Bonartsev, A.; & Bonartseva, G. (2008). Effect of 
growth conditions on the molecular weight of polyhydroxybutyrate produced by 
Azotobacter chroococcum 7B, Applied Biochemistry and Microbiology, 44 (5), 482-486. 
Myshkina, V.; Ivanov, E.; Nikolaeva, D.; Makhina T.; Bonartsev A.; Filatova E.; Ruzhitsky A. 
& Bonartseva G. (2010). Biosynthesis of poly-ǃ-hydroxybutyrate-co-
hydroxyvalerate copolymer by Azotobacter chroococcum strain 7B. Applied 
biochemistry and microbiology, 46 (3), 289.296. 
Noguez, R.; Segura, D.; Moreno, S.; Hernández, A.; Juárez, K. & Espín, G. (2008). Enzyme 
INtr, NPr and IIANtr are involved in regulation of the poly-ǃ-hydroxybutyrate 
biosynthetic genes in Azotobacter vinelandii. Journal of Molecular Microbiology and 
Biotechnology 15, 244-254. 
Page, W. & Knosp, O. (1989). Hyperproduction of polyhydroxybutyrate during exponential 
growth of Azotobacter vinelandii UWD, Applied and Environmental Microbiology, 55(6), 
1334-1339. 
Page, W.; Manchak, J. & Rudy, B. (1992). Formation of poly(hydroxybutyrate-co-
hydroxyvalerate) by Azotobacter vinelandii UWD. Applied and Environmental 
Microbiology, 58, 2866-2873. 
Page, W. (1992). Production of polyhydroxyalkanoates by Azotobacter vinelandii UWD in beet 
molasses culture, FEMS Microbiology Reviews, 103,149-158. 
Page, W. & Cornish, A. (1993). Growth of Azotobacter vinelandii UWD in Fish Peptone 
Medium and Simplified Extraction of Poly--hydroxybutyrate. Applied and 
Environmental Microbiology, 59, 4236-4244. 
www.intechopen.com
Bioprocess Design: Fermentation Strategies for Improving  
the Production of Alginate and Poly-Hydroxyalkanoates (PHAs) by Azotobacter vinelandii 
 
239 
Page, W.; Tindale, A.; Chandra, M. & Kwon E. (2001). Alginate formation in Azotobacter 
vinelandii UWD during stationary phase and the turnover polyhydroxybutyrate. 
Microbiology, 147, 483-490. 
Parente, E.; Crudele, M.; Ricciardi,  A.; Mancini, M.; Clementi F. (2000). Effect of ammonium 
sulphate concentration and agitation speed on the kinetics of alginate production 
by Azotobacter vinelandii DSM576 in batch fermentation. Journal of Industrial 
Microbiology and Biotechnology, 25, 242-248 
Peña, C.; Campos, N.; Galindo, E. (1997) Changes in alginate molecular mass distributions, 
broth viscosity and morphology of Azotobacter vinelandii cultured in shake flasks. 
Applied Microbiology and Biotechnology, 48, 510-515.  
Peña, C.; Trujillo-Roldan, M. & Galindo, E. (2000). Influence of dissolved oxygen tension and 
agitation speed on alginate production and its molecular weight in cultures of 
Azotobacter vinelandii. Enzyme and Microbiology Technology, 27, 390-398.  
Peña, C.; Hernandez, L. & Galindo, E. (2006) Manipulation of the acetylation degree of 
Azotobacter vinelandii alginate by supplementing the culture medium with 3-(N-
morpholino)-propane-sulfonic acid. Letters of Applied Microbiology, 43, 200-204. 
Peña, C.; Peter, C.; Büchs, J. & Galindo, E. (2007) Evolution of the specific power 
consumption and oxygen transfer rate in alginate-producing cultures of Azotobacter 
vinelandii conducted in shake flasks. Biochemical Engineering Journal, 36: 73-80. 
Peña, C.; Millán, M. & Galindo, E. (2008). Production of alginate by Azotobacter vinelandii in a 
stirred fermentor simulating the evolution power input observed in shake flasks. 
Processes of Biochemistry, 43, 775-778. 
Peña, C.; Galindo, E.; Büchs, J. (2011). The viscosifying power, degree acetylation and 
molecular mass of the alginate produced by Azotobacter vinelandii in shake flasks are 
determined by the oxygen transfer rate. Process Biochemistry, 46, 290-297. 
Peralta-Gil, M.; Segura, D.; Guzmán, J.; Servin-Gonzalez, L. & Espin, G. (2002). Expression of 
the Azotobacter vinelandii poly-beta-hydroxybutyrate biosynthetic phbBAC operon is 
driven by two overlapping promoters and is dependent on the transcriptional 
activator PhbR. Journal of Bacteriology, 184, 5672-5677. 
Peters, V. & Rehm, B. (2008). Protein engineering of streptavidin for in vivo assembly of 
streptavidin beads. Journal of Biotechnology, 134, 266–274. 
Pindar, D. & Bucke, C. (1975). The biosynthesis of alginic acid by Azotobacter vinelandii. 
Biochemistry Journal, 152, 617-622. 
Poole, R. & Hill, S. (1997). Respiratory protection of nitrogenase activity in Azotobacter 
vinelandii, roles of the terminal oxidases. Biosciences Reports, 17, 303-317. 
Post, E.; Kleiner, D. & Oelze, J. (1983). Whole cell respiration and nitrogenase activities in 
Azotobacter vinelandii growing in oxygen controlled continuous culture. Archives of 
Microbiology, 134, 68-72. 
Priego-Jiménez, R.; Peña, C.; Ramírez, O.T.; Galindo, E. (2005). Specific growth rate 
determines the molecular weight of the alginate produced by Azotobacter vinelandii. 
Biochemistry Engineering Journal, 25, 187-193. 
Pyla, R.; Kim, T.; Silva, J. & Jung, Y. (2009). Overproduction of poly-beta-hydroxybutyrate in 
the Azotobacter vinelandii mutant that does not express small RNA ArrF. Applied 
Microbiology and Biotechnology, 84 (49), 717-724. 
www.intechopen.com
Progress in Molecular and Environmental Bioengineering  
– From Analysis and Modeling to Technology Applications 
 
240 
Quagliano, J. & Miyazaki, S. (1997). Effect of aeration and carbon/nitrogen ratio on the 
molecular mass of the biodegradable polymer poly-ǃ-hydroxybutyrate obtained 
from Azotobacter chroococcum 6B, Applied microbiology and biotechnology, 48, 662-664. 
Remminghorst, U. & Rehm, B. (2006). Bacterial alginates: from biosynthesis to applications. 
Biotechnology Letters, 28, 1701-1712.  
Reyes, C.; Peña, C. & Galindo, E. (2003). Reproducing shake flasks performance in stirred 
fermentors: production of alginates by Azotobacter vinelandii. Journal of Biotechnology, 
105, 189-198. 
Ruth, K.; Grubelnik, A.; Hartman, R.; Egli, T.; Zinn, M.; & Ren Q. (2007). Efficient production 
of (R)-ǃ-hydroxycarboxylic acids by biotechnological conversion of 
Polyhydroxyalkanoates and their purification. Biomacromolecules. 8(1), 279-286. 
Sabra, W.; Zeng, A.; Sabry, S.; Omar, S. & Deckwer, W-D. (1999). Effect of phosphate and 
oxygen concentrations on alginate production and stoichiometry of metabolism of 
Azotobacter vinelandii under microaerobic conditions. Applied Microbiology and 
Biotechnology, 52, 773-780.  
Sabra, W.; Zeng, A.; Lunsdorf, H. & Deckwer, W-D. (2000). Effect of oxygen on formation 
and structure of Azotobacter vinelandii alginate and its role in protecting nitrogenase 
Applied and Environmental Microbiology, 66, 4037-4044. 
Sabra, W.; Zeng, A. & Deckwer, W.D. (2001). Bacterial alginate: physiology, product quality 
and process aspects. Applied Microbiology and Biotechnology, 56, 315-325. 
Sabra, W. & Zeng, A. (2009). Microbial production of alginates: Physiology and Process 
Aspects, In: Alginates: Biology and Applications, Bernd H. A. Rehm, 153-173, 
Microbiology Monographs Vol. 13, Springer Verlag, DOI: 10.1007/978-3-540-92679-
5, Berlín-Heidelberg. 
Saude, N. & Junter, G. (2002). Production and molecular weight characteristics of alginate 
from free and immobilized-cell cultures of Azotobacter vinelandii. Process 
Biochemistry 2 (37), 895-900.  
Segura, D. & Espin, G. (1998). Mutational inactivation of a gene homologous to Escherichia 
coli ptsP affects poly-beta-hydroxybutyrate accumulation and nitrogen fixation in 
Azotobacter vinelandii. Journal of Bacteriology, 180, 4790-4798. 
Segura, D.; Vargas, E. & Espín, G. (2000). Beta-ketothiolase genes in Azotobacter vinelandii. 
Gene, 260,113-120. 
Segura, D.; Cruz, T. & Espin, G. (2003a). Encystment and alkylresorcinol production by 
Azotobacter vinelandii strains impaired in polybeta- hydroxybutyrate synthesis. 
Archives of Microbiology, 179, 437-443. 
Segura, D.; Guzmán, J.; & Espín, G. (2003b). Azotobacter vinelandii mutants that overproduce 
poly-beta-hydroxybutyrate or alginate. Applied Microbiology and Biotechnology, 63, 
159-163. 
Senior, P. & Dawes, E. (1971). Poly-ǃ-hydroxybutyrate biosynthesis and the regulation of 
glucose metabolism in Azotobacter beijerinckii. Biochemistry Journal, 125, 55–66. 
Senior, P.; Beech, G.; Ritchie, G. & Dawes, E. (1972). The role of oxygen limitation in the 
formation of poly-ǃ-hydroxybutyrate during batch and continuous culture of 
Azotobacter beijerinckii. Biochemistry Journal, 128, 1193–1201. 
Senior, P. & Dawes, E. (1973). The regulation of poly-ǃ-hydroxybutyrate metabolism in 
Azotobacter beijerinckii. Biochemistry Journal, 134, 225–238. 
www.intechopen.com
Bioprocess Design: Fermentation Strategies for Improving  
the Production of Alginate and Poly-Hydroxyalkanoates (PHAs) by Azotobacter vinelandii 
 
241 
Setubal, J.; dos Santos, P.; Goldman, B.; Ertesvåg, H.; Espin, G.; Rubio, L.; Valla, S.; Almeida, 
N.; Balasubramanian, D.; Cromes, L.; Curatti, L.; Du, Z.; Godsy, E.; Goodner, B.; 
Hellner-Burris, K.; Hernandez, J.; Houmiel, K.; Imperial, J.; Kennedy, C.; Larson, T.; 
Latreille, P.; Ligon, L.S.; Lu, J.; Mærk, M.; Miller, N.; Norton, S.; O’Carroll, I.; 
Paulsen, I.; Raulfs, E.; Roemer, R.; Rosser, J.; Segura, D.; Slater, S.; Stricklin, S.; 
Studholme, D.; Sun, J.; Viana, C.; Wallin, E.; Wang, B.; Wheeler, C.; Zhu, H.; Dean, 
D.; Dixon, R. & Wood, D. (2009). The genome sequence of Azotobacter vinelandii, an 
obligate aerobe specialized to support diverse anaerobic metabolic processes. 
Journal of Bacteriology. 191(14), 4534-4545. 
Skjak-Braek, G.; Grasdalen, H. & Larsen, B. (1986). Monomer sequence and acetylation 
pattern in some bacterial alginates. Carbohydrates Research, 154, 239-250. 
Smidsrod, O. & Draget, K. (1996). Chemistry and physical properties of alginates. 
Carbohydrates European, 14, 6-12. 
Socolofsky, M. & Wyss, O. (1962). Resistance of the Azotobacter cyst. Journal of Bacteriology, 
84, 119-124. 
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